Effect of Ly49 haplotype variance on NK cell function and education

Journal of Immunology

Volumn 185, Issue 8, 2010, Pages 4783-4792

  Patel, Rajen ^a   Bélanger, Simon ^b   Tai, Lee Hwa ^b   Troke, Angela D ^a   Makrigiannis, Andrew P ^a,b  

^a UNIVERSITY OF OTTAWA   (Canada)

^b MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; NATURAL KILLER CELL LECTIN LIKE RECEPTOR SUBFAMILY A; NATURAL KILLER CELL RECEPTOR NKG2A; HLA ANTIGEN CLASS 1;

ANIMAL CELL; ARTICLE; C57BL 6 MOUSE; CELL ACTIVITY; CELL FUNCTION; CELL MATURATION; COMPARATIVE STUDY; CONTROLLED STUDY; GENE CLUSTER; GENE NUMBER; GENETIC EPISTASIS; GENETIC VARIABILITY; HAPLOTYPE; IN VITRO STUDY; IN VIVO STUDY; INBRED STRAIN; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; TARGET CELL; ANIMAL; C57BL MOUSE; CELL SEPARATION; CONGENIC STRAIN; CYTOTOXICITY; FLOW CYTOMETRY; GENETICS; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SINGLE NUCLEOTIDE POLYMORPHISM; SOUTHERN BLOTTING;

ANIMALS; BLOTTING, SOUTHERN; CELL SEPARATION; CYTOTOXICITY, IMMUNOLOGIC; FLOW CYTOMETRY; HAPLOTYPES; HISTOCOMPATIBILITY ANTIGENS CLASS I; KILLER CELLS, NATURAL; LYMPHOCYTE ACTIVATION; MICE; MICE, CONGENIC; MICE, INBRED C57BL; NK CELL LECTIN-LIKE RECEPTOR SUBFAMILY A; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 78049505957     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1001287     Document Type: Article

References (46)

1. Kärre, K., H. G. Ljunggren, G. Piontek, and R. Kiessling. 1986. Selective rejection of H-2-deficient lymphoma variants suggests alternative immune defence strategy. Nature 319:675-678.
2. Lanier, L. L. 2005. NK cell recognition. Annu. Rev. Immunol. 23:225-274.
3. Ravetch, J. V., and L. L. Lanier. 2000. Immune inhibitory receptors. Science 290:84-89.
4. Arase, H., E. S. Mocarski, A. E. Campbell, A. B. Hill, and L. L. Lanier. 2002. Direct recognition of cytomegalovirus by activating and inhibitory NK cell receptors. Science 296:1323-1326.
5. Kielczewska, A., M. Pyzik, T. Sun, A. Krmpotic, M. B. Lodoen, M. W. Munks, M. Babic, A. B. Hill, U. H. Koszinowski, S. Jonjic, et al. 2009. Ly49P recognition of cytomegalovirus-infected cells expressing H2-Dk and CMV-encoded m04 correlates with the NK cell antiviral response. J. Exp. Med. 206:515-523.
6. Furukawa, H., K. Iizuka, J. Poursine-Laurent, N. Shastri, and W. M. Yokoyama. 2002. A ligand for the murine NK activation receptor Ly-49D: activation of tolerized NK cells from beta 2-microglobulin-deficient mice. J. Immunol. 169:126-136.
7. Kane, K. P., E. T. Silver, and B. Hazes. 2001. Specificity and function of activating Ly-49 receptors. Immunol. Rev. 181:104-114.
8. Ljunggren, H. G., and K. Kärre. 1990. In search of the 'missing self': MHC molecules and NK cell recognition. Immunol. Today 11:237-244.
9. Ljunggren, H. G., L. Van Kaer, H. L. Ploegh, and S. Tonegawa. 1994. Altered natural killer cell repertoire in Tap-1 mutant mice. Proc. Natl. Acad. Sci. USA 91:6520-6524. (Pubitemid 24200693)
10. Liao, N. S., M. Bix, M. Zijlstra, R. Jaenisch, and D. Raulet. 1991. MHC class I deficiency: susceptibility to natural killer (NK) cells and impaired NK activity. Science 253:199-202.
11. Höglund, P., C. Ohlén, E. Carbone, L. Franksson, H. G. Ljunggren, A. Latour, B. Koller, and K. Kärre. 1991. Recognition of beta 2-microglobulin-negative (beta 2m-) T-cell blasts by natural killer cells from normal but not from beta 2m-mice: nonresponsiveness controlled by beta 2m-bone marrow in chimeric mice. Proc. Natl. Acad. Sci. USA 88:10332-10336.
12. Ohlén, C., G. Kling, P. Höglund, M. Hansson, G. Scangos, C. Bieberich, G. Jay, and K. Kärre. 1989. Prevention of allogeneic bone marrow graft rejection by H-2 transgene in donor mice. Science 246:666-668.
13. Brodin, P., T. Lakshmikanth, S. Johansson, K. Kärre, and P. Höglund. 2009. The strength of inhibitory input during education quantitatively tunes the functional responsiveness of individual natural killer cells. Blood 113:2434-2441.
14. Kim, S., J. Poursine-Laurent, S. M. Truscott, L. Lybarger, Y. J. Song, L. Yang, A. R. French, J. B. Sunwoo, S. Lemieux, T. H. Hansen, and W. M. Yokoyama. 2005. Licensing of natural killer cells by host major histocompatibility complex class I molecules. Nature 436:709-713.
15. Fernandez, N. C., E. Treiner, R. E. Vance, A. M. Jamieson, S. Lemieux, and D. H. Raulet. 2005. A subset of natural killer cells achieves self-tolerance without expressing inhibitory receptors specific for self-MHC molecules. Blood 105:4416-4423.
16. Joncker, N. T., N. C. Fernandez, E. Treiner, E. Vivier, and D. H. Raulet. 2009. NK cell responsiveness is tuned commensurate with the number of inhibitory receptors for self-MHC class I: the rheostat model. J. Immunol. 182:4572-4580.
17. Carlyle, J. R., A. Mesci, J. H. Fine, P. Chen, S. Bélanger, L. H. Tai, and A. P. Makrigiannis. 2008. Evolution of the Ly49 and Nkrp1 recognition systems. Semin. Immunol. 20:321-330.
18. Carlyle, J. R., A. Mesci, B. Ljutic, S. Belanger, L. H. Tai, E. Rousselle, A. D. Troke, M. F. Proteau, and A. P. Makrigiannis. 2006. Molecular and genetic basis for straindependent NK1.1 alloreactivity of mouse NK cells. J. Immunol. 176:7511-7524.
19. Yokoyama, W. M., L. B. Jacobs, O. Kanagawa, E. M. Shevach, and D. I. Cohen. 1989. A murine T lymphocyte antigen belongs to a supergene family of type II integral membrane proteins. J. Immunol. 143:1379-1386.
20. Belanger, S., L. H. Tai, S. K. Anderson, and A. P. Makrigiannis. 2008. Ly49 cluster sequence analysis in a mouse model of diabetes: an expanded repertoire of activating receptors in the NOD genome. Genes Immun. 9:509-521.
21. Idris, A. H., K. Iizuka, H. R. Smith, A. A. Scalzo, and W. M. Yokoyama. 1998. Genetic control of natural killing and in vivo tumor elimination by the Chok locus. J. Exp. Med. 188:2243-2256.
22. Lee, S. H., A. Zafer, Y. de Repentigny, R. Kothary, M. L. Tremblay, P. Gros, P. Duplay, J. R. Webb, and S. M. Vidal. 2003. Transgenic expression of the activating natural killer receptor Ly49H confers resistance to cytomegalovirus in genetically susceptible mice. J. Exp. Med. 197:515-526.
23. Mehta, I. K., J. Wang, J. Roland, D. H. Margulies, and W. M. Yokoyama. 2001. Ly49A allelic variation and MHC class I specificity. Immunogenetics 53:572-583.
24. Makrigiannis, A. P., E. Rousselle, and S. K. Anderson. 2004. Independent control of Ly49g alleles: implications for NK cell repertoire selection and tumor cell killing. J. Immunol. 172:1414-1425.
25. Kiessling, R., E. Klein, and H. Wigzell. 1975. "Natural" killer cells in the mouse. I. Cytotoxic cells with specificity for mouse Moloney leukemia cells. Specificity and distribution according to genotype. Eur. J. Immunol. 5:112-117.
26. Makrigiannis, A. P., D. Patel, M. L. Goulet, K. Dewar, and S. K. Anderson. 2005. Direct sequence comparison of two divergent class I MHC natural killer cell receptor haplotypes. Genes Immun. 6:71-83.
27. McVicar, D. W., R. Winkler-Pickett, L. S. Taylor, A. Makrigiannis, M. Bennett, S. K. Anderson, and J. R. Ortaldo. 2002. Aberrant DAP12 signaling in the 129 strain of mice: implications for the analysis of gene-targeted mice. J. Immunol. 169:1721-1728.
28. Pérarnau, B., M. F. Saron, B. R. San Martin, N. Bervas, H. Ong, M. J. Soloski, A. G. Smith, J. M. Ure, J. E. Gairin, and F. A. Lemonnier. 1999. Single H2Kb, H2Db and double H2KbDb knockout mice: peripheral CD8+ T cell repertoire and anti-lymphocytic choriomeningitis virus cytolytic responses. Eur. J. Immunol. 29:1243-1252.
29. Tai, L. H., M. L. Goulet, S. Belanger, N. Toyama-Sorimachi, N. Fodil-Cornu, S. M. Vidal, A. D. Troke, D. W. McVicar, and A. P. Makrigiannis. 2008. Positive regulation of plasmacytoid dendritic cell function via Ly49Q recognition of class I MHC. J. Exp. Med. 205:3187-3199.
30. Desrosiers, M. P., A. Kielczewska, J. C. Loredo-Osti, S. G. Adam, A. P. Makrigiannis, S. Lemieux, T. Pham, M. B. Lodoen, K. Morgan, L. L. Lanier, and S. M. Vidal. 2005. Epistasis between mouse Klra and major histocompatibility complex class I loci is associated with a new mechanism of natural killer cell-mediated innate resistance to cytomegalovirus infection. Nat. Genet. 37:593-599.
31. Makrigiannis, A. P., A. T. Pau, A. Saleh, R. Winkler-Pickett, J. R. Ortaldo, and S. K. Anderson. 2001. Class I MHC-binding characteristics of the 129/J Ly49 repertoire. J. Immunol. 166:5034-5043.
32. Bix, M., N. S. Liao, M. Zijlstra, J. Loring, R. Jaenisch, and D. Raulet. 1991. Rejection of class I MHC-deficient haemopoietic cells by irradiated MHC-matched mice. Nature 349:329-331.
33. Roth, C., J. R. Carlyle, H. Takizawa, and D. H. Raulet. 2000. Clonal acquisition of inhibitory Ly49 receptors on developing NK cells is successively restricted and regulated by stromal class I MHC. Immunity 13:143-153.
34. Johansson, S., M. Johansson, E. Rosmaraki, G. Vahlne, R. Mehr, M. Salmon-Divon, F. Lemonnier, K. Kärre, and P. Höglund. 2005. Natural killer cell education in mice with single or multiple major histocompatibility complex class I molecules. J. Exp. Med. 201:1145-1155.
35. Lucas, M., W. Schachterle, K. Oberle, P. Aichele, and A. Diefenbach. 2007. Dendritic cells prime natural killer cells by trans-presenting interleukin 15. Immunity 26:503-517.
36. Wilson, M. J., M. Torkar, A. Haude, S. Milne, T. Jones, D. Sheer, S. Beck, and J. Trowsdale. 2000. Plasticity in the organization and sequences of human KIR/ILT gene families. Proc. Natl. Acad. Sci. USA 97:4778-4783.
37. Martin, M. P., X. Gao, J. H. Lee, G. W. Nelson, R. Detels, J. J. Goedert, S. Buchbinder, K. Hoots, D. Vlahov, J. Trowsdale, et al. 2002. Epistatic interaction between KIR3DS1 and HLA-B delays the progression to AIDS. Nat. Genet. 31:429-434.
38. Brown, M. G., A. O. Dokun, J. W. Heusel, H. R. Smith, D. L. Beckman, E. A. Blattenberger, C. E. Dubbelde, L. R. Stone, A. A. Scalzo, and W. M. Yokoyama. 2001. Vital involvement of a natural killer cell activation receptor in resistance to viral infection. Science 292:934-937.
39. Martin, M. P., G. Nelson, J. H. Lee, F. Pellett, X. Gao, J. Wade, M. J. Wilson, J. Trowsdale, D. Gladman, and M. Carrington. 2002. Cutting edge: susceptibility to psoriatic arthritis: influence of activating killer Ig-like receptor genes in the absence of specific HLA-C alleles. J. Immunol. 169:2818-2822.
40. Held, W., and D. H. Raulet. 1997. Ly49A transgenic mice provide evidence for a major histocompatibility complex-dependent education process in natural killer cell development. J. Exp. Med. 185:2079-2088.
41. Hanke, T., H. Takizawa, and D. H. Raulet. 2001. MHC-dependent shaping of the inhibitory Ly49 receptor repertoire on NK cells: evidence for a regulated sequential model. Eur. J. Immunol. 31:3370-3379.
42. Kumánovics, A., A. Madan, S. Qin, L. Rowen, L. Hood, and K. Fischer Lindahl. 2002. QUOD ERAT FACIENDUM: sequence analysis of the H2-D and H2-Q regions of 129/SvJ mice. Immunogenetics 54:479-489.
43. Johansson, S. E., H. Hall, J. Björklund, and P. Höglund. 2004. Broadly impaired NK cell function in non-obese diabetic mice is partially restored by NK cell activation in vivo and by IL-12/IL-18 in vitro. Int. Immunol. 16:1-11.
44. Idris, A. H., H. R. Smith, L. H. Mason, J. R. Ortaldo, A. A. Scalzo, and W. M. Yokoyama. 1999. The natural killer gene complex genetic locus Chok encodes Ly-49D, a target recognition receptor that activates natural killing. Proc. Natl. Acad. Sci. USA 96:6330-6335.
45. Mason, L. H. 2000. Recognition of CHO cells by inhibitory and activating Ly-49 receptors. J. Leukoc. Biol. 68:583-586.
46. Orr, M. T., W. J. Murphy, and L. L. Lanier. 2010. 'Unlicensed' natural killer cells dominate the response to cytomegalovirus infection. Nat. Immunol. 11:321-327.